跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-AMITRIPTYLINE TABLET 25 mg - HSA Drug Approval Details
Approvals
/
HSA
/
APO-AMITRIPTYLINE TABLET 25 mg
Approved
THERAPEUTIC
APO-AMITRIPTYLINE TABLET 25 mg
APOTEX INC
🇸🇬 Health Sciences Authority
Approval Date
Mar 15, 1988
Approval ID
facd452e98f7523d
Company
APOTEX INC
Type
Therapeutic
Approval Details
Approval Id
facd452e98f7523d
Drug Name
APO-AMITRIPTYLINE TABLET 25 mg
Product Name
APO-AMITRIPTYLINE TABLET 25 mg
Approval Number
SIN00090P
Approval Date
1988-03-15
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
N06AA09
Atc Item Name
amitriptyline
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
AMITRIPTYLINE HCl
25 mg
AMITRIPTYLINE HCL
25 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 15, 1988
Approval ID
facd452e98f7523d
Type
Therapeutic
Back to HSA Approvals